Infraredx said it inked a deal with HealthTrust Purchasing Group for its TVC imaging system, which uses both near-infrared spectroscopy and intravascular ultrasound to provide images of coronary blood vessels.
Premier Inc. (NSDQ:PINC) announced this week that it added 7 healthcare providers to its bundled payment collaborative. The deal adds healthcare providers in California, Ohio and Virginia.
GHX landed a contract with Premier healthcare alliance to partner on its a "Collaboration Portal," a software system that allows distributors and trading partners to sync up on contract pricing and avoid errors.
Premier Healthcare Alliance struck a deal for blood glucose meters, reagents, and consumables and acute care service with Nova Biomedical of Waltham, Mass. and Roche Diagnostics (PINK:RHHBY) of Indianapolis, Ind.
Group purchasing organization Premier Healthcare Alliance struck a deal with 4 major players in the cardiac device market for several cardiac rhythm management device portfolios.
Johnson & Johnson (NYSE:JNJ) may be worth more in pieces than it is as a whole, at least according to analysts at Goldman Sachs.
Goldman published a research report suggesting that the health care giant split into separate medical device, drug and consumer goods divisions.
HeartWare International (NSDQ:HTWR) completed enrollment in a 450-patient pivotal trial considering its ventricular assist system as a destination therapy for patients with advanced heart failure.
The foofaraw over St. Jude Medical‘s (NYSE:STJ) recalled Riata defibrillator leads is slated for top billing at the upcoming annual meeting of the Heart Rhythm Society in Boston, according to a pair of Leerink Swann analysts.
The message to Medtronic’s (NYSE:MDT) spine business from chairman and CEO Omar Ishrak was clear today: Shape up or ship out.
During a conference call with analysts to discuss the med-tech titan’s fiscal 3rd-quarter results, Ishrak said he was “not happy” that the division posted a 9% revenue decline and warned that the spine unit must raise its game or face the consequences.
Hospital purchasing organization Premier Inc. announced a fifth contract this week with news that the Charlotte, N.C.-based GPO would begin providing creatinine hand-held analyzers to certain levels of its membership.
The devices, which are used to assess renal function at bedside, are developed by Nova Biomedical Corp. of Waltham, Mass.
MassDevice Network
@MassDevice
LinkedIn
YouTube